MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The Superior Colliculus is impaired in de novo Parkinson’s disease patients

    E. BELLOT, E. BELLOT, V. COIZET, S. MEONI, P. PELISSIER, B. DEBU, M. DOJAT, E. MORO (LA TRONCHE, France)

    Objective: To study the function of the Superior Colliculus (SC) in de novo Parkinson’s disease (PD) patients. Background: The SC function is impaired in parkinsonian…
  • 2017 International Congress

    Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

    A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)

    Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…
  • 2017 International Congress

    Evaluating Non-Motor Fluctuations in Parkinson’s Disease Using a Visual Analogue Scale

    E. Brown, K. Dodenhoff, J. Ostrem, C. Racine (San Francisco, CA, USA)

    Objective: To further understand non-motor fluctuations (NMF) and their relationship to other symptoms of Parkinson’s disease (PD) in a deep brain stimulation (DBS) population. Background:…
  • 2017 International Congress

    Investigating the Association between Anxiety and Cognitive Impairment in Parkinson’s Disease: A Descriptive Study

    A. Toft, J. Yang, G. Byrne, J. O'Sullivan, L. Mitchell, D. Copland, N. Dissanayaka (Brisbane, Australia)

    Objective: This study investigated the relationship between anxiety and cognitive impairment in PD. Background: Anxiety and cognitive impairment are prevalent non-motor complications in PD. The…
  • 2017 International Congress

    Probiotic correction of intestinal dysbiosis in Parkinson’s disease

    I. Miliukhina, E. Ermolenko, A. Ivanova, M. Kotyleva, A. Suvorov (Saint-Petersburg, Russian Federation)

    Objective: To reveal the effect of probiotic on the content and condition of intestinal microbiota in Parkinson's disease (PD). Background: Constipation is an important non-motor…
  • 2017 International Congress

    The impact of intensive voice treatment on swallowing in Parkinson disease

    D. McFarland, L. Ramig, B. Martin-Harris, K. Humphries, J. Logemann, K. Freeman, A. Halpern, J. Spielman (Montréal, QC, Canada)

    Objective: Objective:  To analyze the cross-system impact of an intensive voice treatment (LSVT LOUD®) on the swallowing impairments associated with Parkinson disease (PD). Background: Background: …
  • 2017 International Congress

    Prevalence of burning mouth syndrome in Parkinson disease

    X.X. Yu, H. Fernandez (Cleveland, OH, USA)

    Objective: 1. To estimate the prevalence of BMS in PD patients, compared with healthy controls.2. To identify potential factors associated with the presence or severity…
  • 2017 International Congress

    Tyrosine kinase inhibition clears Tau and reserves neuropathology and motor symptoms in a novel model of progressive supranuclear palsy

    Y. Torres-Yaghi, F. Pagan, A. Lawler, T. Kimbason, N. Starr, B. Wilmarth, M. Arellano, M. Javidnia, M. Hebron, C. Moussa (Washington, DC, USA)

    Objective: Our objective was to examine the effects of tau accumulation in transgenic mice, observing both motor function and behavior.  Background: Tau hyper-phosphorylation is a…
  • 2017 International Congress

    Differential diagnosis of Parkinson’s Disease and Progressive Supranuclear Palsy

    Y. Trufanov (Kyiv, Ukraine)

    Objective: The description of differential diagnostic features of PSP and PD in order to improve the diagnosis and the differential diagnosis of these diseases. Background:…
  • 2017 International Congress

    An evaluation of the diagnostic utility of radiological biomarkers in PSP

    J. Whitwell, G. Hoglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, R. Dodel, T. van Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Respondek, G. Rabinovici, J. Rowe, M. Stamelou, K. Josephs (Rochester, MN, USA)

    Objective: To critically evaluate the degree to which structural and molecular radiologic metrics fulfill criteria for diagnostic biomarkers of progressive supranuclear palsy (PSP). Background: PSP…
  • « Previous Page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley